A preliminary mechanistic exploration of the effect of leptin on the docetaxel sensitivity of MDA-MB-231 triple-negative breast cancer cells

被引:0
作者
Gao, Simeng [1 ]
Ding, Sijuan [1 ]
Tang, Zhaohui [1 ]
机构
[1] Cent Hosp Yongzhou, Dept Oncol, 369 Yiyun Rd, Yongzhou 425000, Hunan, Peoples R China
关键词
triple-negative breast cancer; leptin; tumor-associated macrophages; docetaxel; OBESITY; MACROPHAGES; ACTIVATION; EXPRESSION; RECEPTOR;
D O I
10.3892/mco.2024.2722
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer is a common tumor encountered in women, and triple-negative breast cancer (TNBC) has an extremely poor prognosis. The effect of leptin on the docetaxel sensitivity of MDA-MB-231 TNBC cells has not been investigated. The present study aimed to clarify the effect of leptin and M2 tumor-associated macrophages (TAMs) on the chemosensitivity of TNBC cell lines and its possible mechanisms. In the present study, the apoptosis of the MDA-MB-231 cell line was detected at 0, 24, 48 and 72 h using a Cell Counting Kit-8 assay to determine the appropriate concentration of docetaxel as well as the IC50 value. After determining the effect of leptin on TAMs, the conditioned medium with an appropriate concentration of docetaxel was collected to treat the breast cancer cells, and flow cytometry was used to detect the cell cycle distribution and apoptosis in different treatment groups. Interleukin 8 (IL-8) expression was detected using ELISA and western blot assay. The IL-8 antibody was used to neutralize IL-8, and invasion and scratch assays were used to detect changes in invasion and migration of breast cancer cells. Statistical analysis was performed using GraphPad Prism 9.0 and SPSS 22.0. It was revealed that the apoptotic rate of MDA-MB-231 cells in the leptin-treated TAMs group was lower than that in other groups. The expression of IL-8 was notably elevated in the group treated with leptin-activated TAMs compared with that in the other groups. The neutralization of IL-8 resulted in a significant reduction in the invasive migration of MDA-MB-231 cells compared with that in the non-neutralized group.
引用
收藏
页数:8
相关论文
共 32 条
[1]   The multifactorial role of leptin in driving the breast cancer microenvironment [J].
Ando, Sebastiano ;
Catalano, Stefania .
NATURE REVIEWS ENDOCRINOLOGY, 2012, 8 (05) :263-275
[2]   Therapeutic Targeting of the Tumor Microenvironment [J].
Bejarano, Leire ;
Jordao, Marta J. C. ;
Joyce, Johanna A. .
CANCER DISCOVERY, 2021, 11 (04) :933-959
[3]   Leptin promotes migration and invasion of breast cancer cells by stimulating IL-8 production in M2 macrophages [J].
Cao, Hong ;
Huang, Yunxiu ;
Wang, Lin ;
Wang, Hong ;
Pang, Xueli ;
Li, Kuangfa ;
Dang, Weiqi ;
Tang, Hao ;
Wei, Lan ;
Su, Min ;
Tang, Cuiping ;
Chen, Tingmei .
ONCOTARGET, 2016, 7 (40) :65441-65453
[4]   Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020 [J].
Cao, Wei ;
Chen, Hong-Da ;
Yu, Yi-Wen ;
Li, Ni ;
Chen, Wan-Qing .
CHINESE MEDICAL JOURNAL, 2021, 134 (07) :783-791
[5]   Leptin attenuates the anti-estrogen effect of tamoxifen in breast cancer [J].
Chen, Xiaofeng ;
Zha, Xiaoming ;
Chen, Wei ;
Zhu, Tingting ;
Qiu, Jinrong ;
Roe, Oluf Dimitri ;
Li, Jun ;
Wang, Zhaoxia ;
Yin, Yongmei .
BIOMEDICINE & PHARMACOTHERAPY, 2013, 67 (01) :22-30
[6]   Interleukin-8: A chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppression [J].
Fousek, Kristen ;
Horn, Lucas A. ;
Palena, Claudia .
PHARMACOLOGY & THERAPEUTICS, 2021, 219
[7]   Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment [J].
Garrido-Castro, Ana C. ;
Lin, Nancy U. ;
Polyak, Kornelia .
CANCER DISCOVERY, 2019, 9 (02) :176-198
[8]  
Gonzalez-Perez Ruben Rene, 2013, Cancers (Basel), V5, P1140, DOI 10.3390/cancers5031140
[9]   Obesity and breast cancer: status of leptin and adiponectin in pathological processes [J].
Grossmann, Michael E. ;
Ray, Amitabha ;
Nkhata, Katai J. ;
Malakhov, Dmitry A. ;
Rogozina, Olga P. ;
Dogan, Soner ;
Cleary, Margot P. .
CANCER AND METASTASIS REVIEWS, 2010, 29 (04) :641-653
[10]  
Gu L, 2019, MEDICINE, V98, DOI [10.1097/md.0000000000014094, 10.1097/MD.0000000000014094]